Research graph
References from From metabolic syndrome to survival: a prognostic model for PDAC incorporating insulin resistance markers and pathological variables. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
10.3322/caac.21834 · 2024 · External reference
A simple overview of pancreatic cancer treatment for clinical oncologists
10.3390/curroncol30110694 · 2023 · External reference
Pancreatic cancer: A review
10.1001/jama.2021.13027 · 2021 · External reference
Pancreatic ductal adenocarcinoma (PDAC): clinical progress in the last five years
10.1080/13543784.2025.2473698 · 2025 · External reference
Metabolic syndrome, obesity and cancer risk
10.1097/mou.0000000000001041 · 2022 · External reference
Glucose impairments and insulin resistance in prostate cancer: The role of obesity, nutrition and exercise
10.1111/obr.12674 · 2018 · External reference
Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome
10.1201/b16712-22 · 2022 · External reference
Dyslipidemia progression and increased lung cancer risk: A prospective cohort study
10.1007/s10654-024-01175-9 · 2024 · External reference
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
10.1038/s41392-024-02098-3 · 2025 · External reference
Type 2 diabetes and cancer: An umbrella review of observational and mendelian randomization studies
10.1158/1055-9965.epi-20-1245 · 2021 · External reference
Diabetes, pancreatogenic diabetes, and pancreatic cancer
10.2337/db16-1477 · 2017 · External reference
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
10.1016/s2468-1253(16)30106-6 · 2016 · External reference
Type-3c diabetes mellitus, diabetes of exocrine pancreas - An update
10.2174/1573399815666190115145702 · 2019 · External reference
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: Implications for type 3c diabetes
10.1007/s00535-024-02204-w · 2025 · External reference
Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and tryglyceride/glucose index
10.1016/j.dsx.2022.102581 · 2022 · External reference
Triglyceride glucose (TyG) index: A surrogate biomarker of insulin resistance
10.47391/jpma.22-63 · 2022 · External reference
Synergic value of 3D CT-derived body composition and triglyceride glucose body mass for survival prognostic modeling in unresectable pancreatic cancer
10.3389/fnut.2025.1499188 · 2025 · External reference
The triglyceride-glucose index associated with reduced risk of liver metastasis in pancreatic cancer
10.3389/fendo.2025.1592788 · 2025 · External reference
Prognosis of pancreatic head cancer with different patterns of lymph node metastasis
10.1002/jhbp.1159 · 2022 · External reference
Prognostic significance of grade of Malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
10.20892/j.issn.2095-3941.2023.0363 · 2024 · External reference
Prognostic impact of resection margin status in distal pancreatectomy for ductal adenocarcinoma
10.1016/j.hpb.2021.08.323 · 2022 · External reference
Prognosis associated with CA19-9 response dynamics and normalization during neoadjuvant therapy in resected pancreatic adenocarcinoma
10.1097/sla.0000000000005184 · 2023 · External reference
Biomarkers in pancreatic adenocarcinoma: Current perspectives
10.2147/ott.s100510 · 2016 · External reference
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
10.1038/s41575-019-0245-4 · 2020 · External reference
Serum miRNA profiling for early PDAC diagnosis and prognosis: A retrospective study
10.3390/biomedicines9070845 · 2021 · External reference
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
10.1016/j.molonc.2016.01.006 · 2016 · External reference
Circulating tumor cell subpopulations predict treatment outcome in pancreatic ductal adenocarcinoma (PDAC) patients
10.3390/cells12182266 · 2023 · External reference
Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
10.3389/fonc.2023.1074445 · 2023 · External reference
A systematic review of prognosis predictive role of radiomics in pancreatic cancer: Heterogeneity markers or statistical tricks
10.1007/s00330-022-08922-0 · 2022 · External reference
Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
10.1186/s13244-025-01956-0 · 2025 · External reference
Risk factors for pancreatic cancer in patients with new-onset diabetes: A systematic review and meta-analysis
10.3390/cancers14194684 · 2022 · External reference
Long-standing diabetes mellitus increases concomitant pancreatic cancer risk in patients with intraductal papillary mucinous neoplasms
10.21203/rs.3.rs-1721624/v1 · 2022 · External reference
Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma
10.1007/s00125-014-3481-8 · 2015 · External reference
Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: A perspective review
10.1007/s11010-022-04587-x · 2023 · External reference
Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway
10.3389/fendo.2022.1091147 · 2022 · External reference
Stilbenoids from fenugreek seeds alleviate insulin resistance by regulating the PI3K/AKT/mTOR signaling pathway in a type 2 diabetes zebrafish model
10.1016/j.heliyon.2024.e32007 · 2024 · External reference
Insulin resistance in cancer risk and prognosis
10.1016/j.semcancer.2025.06.006 · 2025 · External reference
Prognostic significance of glucose-lipid metabolic index in pancreatic cancer patients with diabetes mellitus
10.1002/cam4.7108 · 2024 · External reference
The relationship between metabolic and inflammatory parameters at the time of diagnosis and disease stage and prognosis in patients with pancreatic cancer
10.1089/met.2024.0210 · 2025 · External reference
Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patients
10.1016/j.intimp.2022.109496 · 2023 · External reference
AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer
10.1002/jcsm.13555 · 2024 · External reference
Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study
10.1002/jcsm.13156 · 2023 · External reference
Cancer cachexia
10.1007/s00423-004-0486-7 · 2010 · External reference
New horizons: Epidemiology of obesity, diabetes mellitus, and cancer prognosis
10.1210/clinem/dgad450 · 2024 · External reference
Obesity and pancreatic cancer
10.1007/978-3-319-42542-9_6 · 2016 · External reference
The role of adipokines in pancreatic cancer
10.3389/fonc.2022.926230 · 2022 · External reference
Hyperinsulinemia in obesity, inflammation, and cancer
10.4093/dmj.2020.0250 · 2021 · External reference
PTEN, insulin resistance and cancer
10.2174/1381612823666170704124611 · 2017 · External reference
Obesity paradox in lung cancer prognosis: Evolving biological insights and clinical implications
10.1016/j.jtho.2017.07.022 · 2017 · External reference
Obesity paradox: Fact or fiction
10.1007/s13679-023-00497-1 · 2023 · External reference
The obesity paradox in cancer: Epidemiologic insights and perspectives
10.1007/s13668-019-00280-6 · 2019 · External reference
Passive smoking and risk of pancreatic cancer: An updated systematic review and meta-analysis
10.7717/peerj.18017 · 2024 · External reference
Cigarette smoking and mortality in patients with pancreatic cancer: A systematic review and meta-analysis
10.1097/mpa.0000000000001383 · 2019 · External reference
Hypertension in cancer survivors
10.1007/s11906-022-01208-2 · 2022 · External reference
Mitochondrial dysfunction in the regulation of aging and aging-related diseases
10.1186/s12964-025-02308-7 · 2025 · External reference
Comorbidity in small cell lung cancer: Prognostic impacts of hypertension/coronary artery disease, diabetes mellitus, and chronic obstructive pulmonary disease
10.1080/07357907.2024.2310574 · 2024 · External reference
Hypertension and chronic kidney disease is highly prevalent in elderly patients with colorectal cancer undergoing primary surgery
10.17219/acem/104537 · 2019 · External reference
Onco-hypertension: An emerging specialty
10.1053/j.ackd.2021.09.011 · 2021 · External reference
Exploring the causal relationship between hemoglobin and pancreatic cancer and its potential mechanisms through bioinformatics and Mendelian randomization
10.1007/s12672-025-03352-y · 2025 · External reference
The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer
10.3390/cancers14133137 · 2022 · External reference
Diagnosis of pernicious anemia and the risk of pancreatic cancer
10.1097/mpa.0000000000000054 · 2014 · External reference
Anemia, iron deficiency, and iron regulators in pancreatic ductal adenocarcinoma patients: A comprehensive analysis
10.3390/curroncol30080560 · 2023 · External reference
Managing Malignant biliary obstruction in pancreas cancer: Choosing the appropriate strategy
10.3748/wjg.v20.i28.9345v · 2014 · External reference
Pathology of pancreatic cancer
10.21037/tgh.2019.06.02 · 2019 · External reference
Pathology of treated pancreatic ductal adenocarcinoma and its clinical implications
10.5858/arpa.2019-0477-ra · 2020 · External reference
Survival prediction in pancreatic ductal adenocarcinoma by quantitative computed tomography image analysis
10.1245/s10434-017-6323-3 · 2018 · External reference
Validation of a prognostic nomogram in patients undergoing resection for pancreatic ductal adenocarcinoma in a UK tertiary referral centre
10.1080/13651820802356606 · 2008 · External reference
A novel combination of SARC-F, GLIM criteria, and calcium levels to predict short-term mortality in hospitalized older adults with advanced-stage cancer
10.6133/apjcn.202606_35(3).0012 · 2026 · External reference
Triglyceride-glucose index and glycemic dynamics in pancreatic ductal adenocarcinoma: Implications for disease progression and prognosis
10.1186/s12967-024-05524-w · 2024 · External reference
